In small-cap investing, “sponsored research” is often treated as a dirty phrase. Investors hear it and immediately think of paid promotion, soft questions, and price targets designed more to support financing activity than to inform serious capital allocation.
That skepticism is rational. In the micro-cap market, many of the best companies are precisely the ones that fall through the cracks of traditional sell-side coverage.
That is the gap Ben and Nicholas, the co-founders of Atrium Research(@Atrium_Research on Twitter), are trying to fill. In a recent conversation, the two laid out how they built Atrium into a respected name in company-sponsored research, why they believe transparency matters more than the illusion of “independence,” and what separates an overlooked small-cap from one that actually deserves investor attention.
The Sell-Side Blind Spot
Plenty of quality small-cap companies go uncovered not because they lack merit, but because they do not generate fees for banks.
As Nicholas put it, “A lot of the best companies out there don’t have sell side coverage because they’re not raising money. So there’s no way for these banks to extract value out of them.” That realization became an essential factor of Atrium’s model. At the time of the interview, the firm covered more than 40 names across industries and market-cap ranges, using research as both an investor tool and a corporate awareness tool.
In other words, Atrium is not pretending the sponsored model does not exist. It is leaning into it openly and trying to execute it at a higher level.
All Research Is Paid for One Way or Another
One of the sharper moments in the discussion came when Nicholas challenged the idea that there is such a thing as perfectly independent research.
“All research is paid for one way or another,” he said. “There’s no such thing as truly independent research. Everybody has some type of motive.” In his view, the difference is not whether incentives exist. The difference is whether those incentives are disclosed and whether the work itself is rigorous.
Atrium’s answer is to keep the model relatively clean. They do not own the stocks they cover. They are paid in cash. And, importantly, many of the companies they work with are sourced by Atrium itself through screens, research, and buy-side referrals rather than inbound requests from low-quality issuers looking for a quick pump. That sourcing discipline matters. It is hard to build trust with investors if the only companies knocking on your door are the ones no serious analyst would touch.
Would They Buy It Themselves?
When asked how they decide whether a company deserves the spotlight, Nicholas avoided offering a rigid formula. Instead, he described a more traditional, holistic process: understand the thesis, assess valuation, evaluate management, and determine whether the business is strong enough to stand on its own.
His simplest test was also the most revealing: “If they make a good enough company that I’d want to invest in them personally, then they’d probably make a good client for Atrium.”
That standard may sound obvious, but in sponsored research it is a meaningful line in the sand. The point is not just to write a polished report. The point is to identify companies that can hold up under real investor scrutiny.
Dynacor
One company that fit Atrium’s framework well was Dynacor. Nicholas described it as a near-perfect case study: a business with a long operating history, consistent growth, cash generation, and dividend growth, yet no analyst coverage.
“The company had a long-term track record,” he said. “They grew revenue and cash flow at a 10% CAGR over a decade, profitable for over a decade, increased the dividend at a 20% rate and they had no analyst coverage.” The reason was not complicated. “They didn’t raise any money. They did this all through cash flow.”
That combination made Dynacor especially compelling for Atrium. It was not dependent on the Street for survival, which meant the absence of coverage said more about broken incentives in capital markets than about the quality of the company itself. Ben added that in mining especially, a dividend-paying, cash-flowing operator is “checking a lot of boxes” in an industry where many companies struggle to make money even after they reach production.
Management Can Make or Break the Thesis
If there was one area where Ben sounded especially firm, it was management quality.
“I believe this to this day,” he said, “that a great manager or great management team can make a mediocre asset work, but a poor management team, even with the best asset in the world, it’s not going to work out.”
That judgment starts with the first conversation. How well does management know the story? How clearly can they explain it? What is the actual plan going forward? Ben argues you can learn a lot very quickly from those answers, and the downstream benefits are obvious: stronger management teams tend to have better access to capital, better relationships, and more levers to keep advancing the business.
Nicholas looks for alignment just as closely. He wants to hear how executives talk about shareholders. He watches whether they are serial diluters, whether they issue stock and options too freely, and whether incentives are actually aligned. “They own a good percentage of the company,” he said, is one of the first things he wants to see. Ben was even more direct: “If they’re telling me to invest in the name, they should be invested as well.”
There is also a qualitative element that many investors underestimate. Ben wants to know whether management can pitch the story coherently at every level. “If they can give you a one minute pitch, if they can give you a five minute pitch, if they can give you a 20 minute pitch and have it all synthesized,” he said, “that checks a lot of boxes.” In public markets, the ability to communicate is not cosmetic. It is part of execution.
What an Atrium Report needs
Atrium’s internal standards for research are also revealing. Ben described the initiation report as the core product: a deep dive followed by update notes as the company executes. But the deep dive has to do more than summarize a business.
First, it needs a real company overview: operations, business model, and how the pieces fit together. Second, and more importantly, it needs a genuine valuation framework. That means a peer-group analysis where appropriate, the right valuation methodology, a target price, and a clear rating. Finally, Atrium tries to distill the whole story into a handful of core investment criteria, such as management strength, peer discount, or industry momentum. The goal, in Ben’s words, is to make the report “a one stop shop for an investor to completely get up to speed on that given story.”
That emphasis matters because too much small-cap content today is either overly promotional or too shallow to be actionable. Atrium is making the case that sponsored work only has a chance of earning respect if it is detailed enough to survive serious due diligence.
Long-Term Thinking in a Tough Market
Nicholas’s answer is not to complain, but to widen the search. “The best thing to do is just turn over a lot of different rocks,” he said. He also noted that thematic work still matters: defense, infrastructure, and precious metals have been fertile areas, and a top-down view can help narrow the field before bottom-up work begins.
But just as important is time horizon. Ben made clear that Atrium is not trying to manufacture a short-term pop. “We’re not trying to pump up the stock on the day that we put out an initiation report,” he said. The ideal reader is someone who studies the thesis, puts the name on a watchlist, follows execution over time, and invests for the “next two, three years to have that full thesis play out.”
That mindset also shaped their commentary on ADF Group, another early Atrium coverage name. They were attracted to the same familiar traits: growth, cash generation, no need for dilution, and no obvious reason for the sell side to care. Even after volatility tied to tariffs and integration concerns around the Lar Group acquisition, they still framed the business through a long-term lens, watching margins and backlog rather than fixating on a single quarter.
Final Take
The strongest takeaway from the interview is not that sponsored research should be trusted blindly. It should not. It is that micro-cap investors should be far more interested in process than labels.
Atrium’s pitch is not that incentives disappear. It is that disciplined screening, transparent economics, real valuation work, and management scrutiny can still produce research worth reading; In a corner of the market where many worthy companies remain underfollowed.
Thank you for your time Ben and Nicholas, appreciate the chat with you guys!
See you soon,
Lukas, Pixel Research
This post is public so feel free to share it, so we can grow this community!
Tickers Mentioned
(TSX:DRX),(TSX:DNG)
Disclaimer
This is not financial advice as Pixel Research content is not meant to be a substitute for financial advice. Since we don’t offer financial advice, the material provided shouldn’t be interpreted as tailored investment advice. It is crucial to carry out in-depth research and, if required, speak with a licensed financial expert before making any financial decisions.
Works Cited:
